Lactulose Breath Test to Assess Oro-cecal Transit Delay and Estimate Esophageal Dysmotility in Scleroderma Patients

被引:28
作者
Gemignani, Lorenzo [1 ]
Savarino, Vincenzo [1 ]
Ghio, Massimo [2 ]
Parodi, Andrea [1 ]
Zentilin, Patrizia [1 ]
de Bortoli, Nicola [3 ]
Negrini, Simone [1 ]
Furnari, Manuele [1 ]
Dulbecco, Pietro [1 ]
Giambruno, Elisa [1 ]
Savarino, Edoardo [1 ,4 ]
机构
[1] Univ Genoa, Gastroenterol Unit, Dept Internal Med, I-16132 Genoa, Italy
[2] Univ Genoa, Clin Immunol Lab, Dept Internal Med, I-16132 Genoa, Italy
[3] Univ Pisa, Gastroenterol Unit, Dept Internal Med, Pisa, Italy
[4] Univ Padua, Dept Surg Oncol & Gastroenterol Sci, Gastroenterol Unit, Padua, Italy
关键词
Lactulose breath test; IEM; Scleroderma; Systemic sclerosis; INTESTINAL BACTERIAL OVERGROWTH; SYSTEMIC-SCLEROSIS; GASTROESOPHAGEAL-REFLUX; GASTROINTESTINAL SYMPTOMS; MOTILITY DISORDERS; CLINICAL-TRIAL; INVOLVEMENT; MANIFESTATIONS; CLASSIFICATION; TIME;
D O I
10.1016/j.semarthrit.2012.09.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To assess the correlation between delayed oro-cecal transit time (OCTT) and esophageal motility abnormalities in a cohort of systemic sclerosis (SSc) patients. Methods: We prospectively enrolled 50 consecutive SSc patients and 60 healthy volunteers (HVs) as controls. Both groups underwent glucose breath test (GBT) to exclude small intestine bacterial overgrowth, lactulose hydrogen, and octanoic acid breath tests (LHBT and OBT) to measure OCTT and gastric emptying (GE), respectively, and manometry to assess esophageal motility. Results: Thirty-one (63%) SSc patients presented ineffective esophageal motility (IEM) compared with 3 HVs (5%; P < 0.01), 37 (74%) had an abnormal OCTT compared with 4 HVs (7%; P < 0.01), and 16 (32%) had an altered GE compared with 4 HVs (7%; P < 0.01). The median OCTT and gastric t(1/2) were longer in SSc than in HVs (165 min vs. 101 min and 125 min vs. 78 min, respectively; P < 0.01). A delayed GE was present in 12/37 (32%), whereas IEM in 27/37 (73%) SSc patients with prolonged OCTT. The prevalence of IEM increased in parallel with the prolongation of OCTT (31% when OCTT < 150 min, 73% when OCTT >= 150 min, and up to 85% when OCTT > 180 min, P < 0.01). Conclusions: Abnormalities of both esophageal and small intestine motility are frequent in SSc patients and esophageal motility is altered in most cases with small bowel involvement. Delayed GE plays a limited role in prolonging OCTT. LHBT is a non-invasive, cheap, well-tolerated diagnostic tool that may be useful to estimate intestinal involvement and also to estimate a higher risk of esophageal hypomotility in SSc patients. (C) 2013 Elsevier Inc. All rights reserved. Semin Arthritis Rheum 42:522-529
引用
收藏
页码:522 / 529
页数:8
相关论文
共 35 条
[1]   Assessment of intestinal permeability and orocecal transit time in patients with systemic sclerosis:: analysis of relationships with epidemiologic and clinical parameters [J].
Caserta, L ;
de Magistris, L ;
Secondulfo, M ;
Caravelli, G ;
Riegler, G ;
Cuomo, G ;
D'Angelo, S ;
Naclerio, C ;
Valentini, G ;
Carratù, R .
RHEUMATOLOGY INTERNATIONAL, 2003, 23 (05) :226-230
[2]   Systemic sclerosis: current views of its pathogenesis [J].
Derk, CT ;
Jimenez, SA .
AUTOIMMUNITY REVIEWS, 2003, 2 (04) :181-191
[3]   Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma [J].
Di Ciaula, Agostino ;
Covelli, Michele ;
Berardino, Massimo ;
Wang, David Q. H. ;
Lapadula, Giovanni ;
Palasciano, Giuseppe ;
Portincasa, Piero .
BMC GASTROENTEROLOGY, 2008, 8 (1)
[4]  
DORIA A, 1991, J RHEUMATOL, V18, P685
[5]   Gastrointestinal complications: the most frequent internal complications of systemic sclerosis [J].
Forbes, A. ;
Marie, I. .
RHEUMATOLOGY, 2009, 48 :36-39
[6]   Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth [J].
Furnari, M. ;
Parodi, A. ;
Gemignani, L. ;
Giannini, E. G. ;
Marenco, S. ;
Savarino, E. ;
Assandri, L. ;
Fazio, V. ;
Bonfanti, D. ;
Inferrera, S. ;
Savarino, V. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (08) :1000-1006
[7]  
Furnari M, 2012, J GASTROINTEST LIVER, V21, P157
[8]   Gastrointestinal transit in patients with systemic sclerosis [J].
Fynne, Lotte ;
Worsoe, Jonas ;
Gregersen, Tine ;
Schlageter, Vincent ;
Laurberg, Soren ;
Krogh, Klaus .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2011, 46 (10) :1187-1193
[9]   Methodology and Indications of H2-Breath Testing in Gastrointestinal Diseases: the Rome Consensus Conference [J].
Gasbarrini, A. ;
Corazza, G. R. ;
Gasbarrini, G. ;
Montalto, M. ;
Di Stefano, M. ;
Basilisco, G. ;
Parodi, A. ;
Satta, P. U. ;
Vernia, P. ;
Anania, C. ;
Astegiano, M. ;
Barbara, G. ;
Benini, L. ;
Bonazzi, P. ;
Capurso, G. ;
Certo, M. ;
Colecchia, A. ;
Cuoco, L. ;
Di Sario, A. ;
Festi, D. ;
Lauritano, C. ;
Miceli, E. ;
Nardone, G. ;
Perri, F. ;
Portincasa, P. ;
Risicato, R. ;
Sorge, M. ;
Tursi, A. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 :1-49
[10]   MEASUREMENT OF GASTRIC-EMPTYING RATE OF SOLIDS BY MEANS OF A CARBON-LABELED OCTANOIC-ACID BREATH TEST [J].
GHOOS, YF ;
MAES, BD ;
GEYPENS, BJ ;
MYS, G ;
HIELE, MI ;
RUTGEERTS, PJ ;
VANTRAPPEN, G .
GASTROENTEROLOGY, 1993, 104 (06) :1640-1647